BioXcel Therapeutics, Inc. (BTAIQ)

Import this data to Google Sheets with:

=jivedata("BTAIQ","financials")

Full statements spill as a table. For one cell: =jivedata("BTAIQ","Revenue") or =jivedata("BTAIQ","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

BioXcel Therapeutics, Inc.

BTAIQ • CIK 0001720893

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Revenue from Contract with Customer, Excluding Assessed Tax	$1,380	$2,266	$642	$742
Operating Income (Loss)	$-171,782	$-67,245	$-50,461	$-44,926
Net Income (Loss) Attributable to Parent	$-179,053	$-59,599	$-69,897	$-70,860
Weighted Average Number of Shares Outstanding, Basic	29,129,000	2,535,000	12,208,000	32,815,000
Cost of Goods and Services Sold	$1,260	$2,143	$164	$348
Research and Development Expense	$84,326	$30,435	$30,251	$21,560
Selling, General and Administrative Expense	$83,413	$34,492	$20,494	$23,566
Restructuring Charges	$4,163	$2,441	$194	$194
Costs and Expenses	$173,162	$69,511	$51,103	$45,668
InterestExpenseNonoperating	—	$15,129	$16,984	$17,224
Investment Income, Interest	$5,649	$2,602	$1,066	$899
Other Nonoperating Income (Expense)	$394	$20,173	$-3,518	$-9,609

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Property, Plant and Equipment, Net	$784	$475	$175	$99
Operating Lease, Right-of-Use Asset	$688	$382	$56	$0
Other Assets, Noncurrent	$87	$87	$0	$0
Assets	$73,702	$38,338	$44,916	$28,799
Operating Lease, Liability, Noncurrent	$440	$65	$0	$0
Derivative Liability, Noncurrent	$1,905	$6,633	$1,790	$7,110
Long-term Debt, Excluding Current Maturities	$100,598	$102,508	$84,663	$0
Liabilities	$130,210	$131,439	$140,379	$144,259
Cash and Cash Equivalents, at Carrying Value	$65,221	$29,854	$28,415	$12,841
Restricted Cash, Current	—	—	$342	$960
Receivables, Net, Current	$71	$131	$233	$82
Inventory, Net	$1,991	$679	$722	$483
Prepaid Expense and Other Assets, Current	$2,782	$5,290	$4,028	$3,074
Other Assets, Current	$2,078	$1,440	$10,945	$11,260
Assets, Current	$72,143	$37,394	$44,685	$28,700
Accounts Payable, Current	$13,654	$15,990	$14,701	$18,783
Accrued Liabilities, Current	$12,424	$5,762	$4,341	$3,921
Long-term Debt, Current Maturities	—	—	$24,931	$104,451
Liabilities, Current	$27,267	$22,233	$53,926	$137,149
Preferred Stock, Value, Issued	—	—	$0	$0
Common Stock, Value, Issued	$30	$49	$76	$31
Additional Paid in Capital	$534,060	$557,047	$624,555	$632,007
Retained Earnings (Accumulated Deficit)	$-590,598	$-650,197	$-720,094	$-747,498
Stockholders' Equity Attributable to Parent	$-56,508	$-93,101	$-95,463	$-115,460
Preferred Stock, Shares Authorized	10,000,000	10,000,000	10,000,000	10,000,000
Preferred Stock, Shares Issued	0	0	0	0
Common Stock, Shares Authorized	100,000,000	200,000,000	200,000,000	200,000,000
Common Stock, Shares, Issued	29,930,000	3,102,000	22,328,000	31,305,000

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$-179,053	$-59,599	$-69,897	$-70,860
Net Cash Provided by (Used in) Operating Activities	$-155,006	$-72,027	$-57,615	$-50,904
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$-128,504	$-35,367	$-1,097	$-4,774
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$65,221	$29,854	$28,757	$14,924
Depreciation	$318	$309	$300	$225
Payments to Acquire Property, Plant, and Equipment	$20	$20	$0	$0
Amortization of Debt Issuance Costs and Discounts	$1,373	$467	$1,652	$2,185
Net Cash Provided by (Used in) Investing Activities	$-20	$-20	$0	$0
Derivative, Gain (Loss) on Derivative, Net	$438	$20,180	$-3,505	$-9,602
Share-based Payment Arrangement, Noncash Expense	$18,614	$6,156	$2,767	$1,824
Paid-in-Kind Interest	$1,872	$6,543	$5,434	$3,410
Operating Lease, Right-of-Use Asset, Amortization Expense	$288	$306	$326	$222
Proceeds from Issuance or Sale of Equity	—	$467	$58,142	$55,603
Repayments of Long-term Debt	—	$2,500	$0	$8,412
Payments of Stock Issuance Costs	$811	$474	$1,607	$1,021
Payment, Tax Withholding, Share-based Payment Arrangement	$27	$54	$17	$40
Net Cash Provided by (Used in) Financing Activities	$26,522	$36,660	$56,518	$46,130
Cash and Cash Equivalents, at Carrying Value	$65,221	$29,854	$28,415	$14,582
Restricted Cash, Current	—	—	$342	—
Adjustments to Additional Paid in Capital, Warrant Issued	$200	$2,540	$0	$7,587
Interest Paid, Excluding Capitalized Interest, Operating Activities	$7,551	$7,968	$9,690	$13,341
Increase (Decrease) in Accounts and Other Receivables	$-177	$60	$102	$65
Increase (Decrease) in Inventories	$6	$-1,312	$43	$-23
Increase (Decrease) in Prepaid Expense and Other Assets	$-2,888	$1,872	$8,156	$8,190
Increase (Decrease) in Other Accounts Payable and Accrued Liabilities	$-3,219	$-4,327	$6,973	$10,976
Increase (Decrease) in Interest Payable, Net	$2,497	$-736	$0	$0
IncreaseDecreaseInOperatingLeaseLiability	$-319	$-346	$-374	$-256

Jive Data

Google Sheets add-onSheets Account

Import this data to Google Sheets with:

=jivedata("BTAIQ","financials")

Full statements spill as a table. For one cell: =jivedata("BTAIQ","Revenue") or =jivedata("BTAIQ","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.